Efficacy of genotype notification to Japanese smokers on smoking cessation-An intervention study at workplace

Cancer Epidemiology

Volumn 34, Issue 1, 2010, Pages 96-100

  Hishida, Asahi ^a   Terazawa, Tetsuro ^b   Mamiya, Toshiko ^b   Ito, Hidemi ^c   Matsuo, Keitaro ^c   Tajima, Kazuo ^c   Hamajima, Nobuyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b The Bank of Tokyo Mitsubishi UFJ (former Tokai Bank)   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Genotype notification; L myc genotype; Smoking cessation

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; JAPANESE; MALE; ONCOGENE MYC; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING CESSATION; WORK ENVIRONMENT;

ADULT; FEMALE; GENES, MYC; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INTERVENTION STUDIES; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; OCCUPATIONAL HEALTH; RISK FACTORS; SMOKING CESSATION; TREATMENT OUTCOME; WORKPLACE; YOUNG ADULT;

EID: 76449094249     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2009.11.008     Document Type: Article

References (39)

1. Ebbert J.O., Sood A., Hays J.T., Dale L.C., and Hurt R.D. Treating tobacco dependence: review of the best and latest treatment options. J Thorac Oncol 2 (2007) 249-256
2. Nishino Y., Inoue M., Tsuji I., Wakai K., Nagata C., Mizoue T., et al. Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Tobacco smoking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 36 (2006) 800-807
3. Nagata C., Mizoue T., Tanaka K., Tsuji I., Wakai K., Inoue M., et al. Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol 36 (2006) 387-394
4. Eguchi H., and Nakachi K. Smoking as a risk factor for pancreatic cancer. Nippon Rinsho 64 Suppl 1 (2006) 10-13 (in Japanese)
5. Mizoue T., Inoue M., Tanaka K., Tsuji I., Wakai K., Nagata C., et al. Research Group for the Development, Evaluation of Cancer Prevention Strategies in Japan. Tobacco smoking and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 36 (2006) 25-39
6. Morgan G.D., Backinger C.L., and Leischow S.J. The future of tobacco-control research. Cancer Epidemiol Biomarkers Prev 16 (2007) 1077-1080
7. Janz N.K., and Becker M.H. The Health Belief Model: a decade later. Health Educ Q 11 (1984) 1-47
8. Witte K. Putting the fear back into fear appeals: the extended parallel process model. Comm Mono 59 (1992) 329-349
9. Etchegary H., and Perrier C. Information processing in the context of genetic risk: implications for genetic-risk communication. J Genet Couns 16 (2007) 419-432
10. Audrain J., Boyd N.R., Roth J., Main D., Caporaso N.F., and Lerman C. Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. Addict Behav 22 (1997) 741-751
11. Lerman C., Gold K., Audrain J., Lin T.H., Boyd N.R., Orleans C.T., et al. Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol 16 (1997) 87-99
12. McBride C.M., Bepler G., Lipkus I.M., Lyna P., Samsa G., Albright J., et al. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol Biomarkers Prev 11 (2002) 521-528
13. Sanderson S.C., Humphries S.E., Hubbart C., Hughes E., Jarvis M.J., and Wardle J. Psycological and behavioural impact of genetic testing smokers for lung cancer risk: a phase II exploratory trial. J Health Psychol 13 (2008) 481-494
14. Ito H., Matsuo K., Wakai K., Saito T., Kumimoto H., Okuma K., et al. An intervention study of smoking cessation with feedback on genetic cancer susceptibility in Japan. Prev Med 42 (2006) 102-108
15. Hamajima N., Suzuki K., Ito Y., and Kondo T. Genotype announcement to Japanese smokers who attended a health checkup examination. J Epidemiol 16 (2006) 45-47
16. Hamajima N., Atsuta Y., Goto Y., and Ito H. A pilot study on genotype announcement to induce smoking cessation by Japanese smokers. Asian Pac J Cancer Prev 5 (2004) 409-413
17. Kano M., Goto Y., Atsuta Y., Naito M., and Hamajima N. Smoking cessation after genotype announcement: pilot studies for smokers employed by a municipal government and for smokers in Nagoya University medical campus. Nagoya J Med Sci 69 (2007) 149-156
18. Kumimoto H., Hamajima N., Nishimoto Y., Matsuo K., Shinoda M., Hatooka S., et al. L-myc genotype is associated with different susceptibility to lung cancer in smokers. Jpn J Cancer Res 93 (2002) 1-5
19. Kumimoto H., Hamajima N., Nishizawa K., Nishimoto Y., Matsuo K., Harada H., et al. Different susceptibility of each L-myc genotype to esophageal cancer risk factors. Jpn J Cancer Res 92 (2001) 735-739
20. Kawashima K., Shikama H., Imoto K., Izawa M., Naruke T., Okabayashi K., et al. Close correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human lung cancer to the lymph nodes and other organs. Proc Natl Acad Sci USA 85 (1988) 2353-2356
21. Spinola M., Pedotti P., Dragani T.A., and Taioli E. Meta-analysis suggests association of L-myc EcoRI polymorphism with cancer prognosis. Clin Cancer Res 10 (2004) 4769-4775
22. Prochaska J.O. Strong and weak principles for progressing from precontemplation to action on the basis of twelve problem behaviors. Health Psychol 13 (1994) 47-51
23. Hamajima N., Saito T., Matsuo K., Kozaki K., Takahashi T., and Tajima K. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 91 (2000) 865-868
24. Hamajima N., Fukumitsu T., Odauchi S., Akashi T., Usui T., and Ido M. A large-scale follow-up study of smokers visiting medical facilities in Japan. Asian Pac J Cancer Prev 2 (2001) 185-191
25. Hamajima N., Kurobe Y., and Tajima K. Smoking cessation rate among outpatients at a cancer hospital. Tob Control 8 (1999) 349-350
26. Farkas A.J., Pierce J.P., Zhu S.H., Rosbrook B., Gilpin E.A., Berry C., et al. Addiction versus stages of change models in predicting smoking cessation. Addiction 91 (1996) 1271-1280 discussion 1281-92
27. John U., Meyer C., Rumpf H.J., and Hapke U. Relation among stage of change, demographic characteristics, smoking history, and nicotine dependence in an adult German population. Prev Med 37 (2003) 368-374
28. Sanderson S.C., and Wardle J. Will genetic testing for complex diseases increase motivation to quit smoking? Anticipated reactions in a survey of smokers. Health Educ Behav 32 (2005) 640-653
29. Ostroff J.S., Hay J.L., Primavera L.H., Bivona P., Cruz G.D., and LeGeros R. Motivating smoking cessation among dental patients: smokers' interest in biomarker testing for susceptibility to tobacco-related cancers. Nicotine Tob Res 1 (1999) 347-355
30. Westmaas J.L., and Woicik P.B. Dispositional motivations and genetic risk feedback. Addict Behav 30 (2005) 1524-1534
31. Andrews L., Meiser B., Apicella C., and Tucker K. Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study. Genet Test 8 (2004) 240-247
32. Esplen M.J., Hunter J., Leszcz M., Warner E., Narod S., Metcalfe K., et al. A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations. Cancer 101 (2004) 2327-2340
33. Tluczek A., Koscik R.L., Farrell P.M., and Rock M.J. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment. Pediatrics 115 (2005) 1692-1703
34. Meiser B., Collins V., Warren R., Gaff C., St. John D.J., Young M.A., et al. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet 66 (2004) 502-511
35. Prochaska J.O., and Velicer W.F. The transtheoretical model of health behavior change. Am J Health Promot 12 (1997) 38-48
36. Noia J.D., and Scinke S.P. Application of the transtheoretical model to fruit and vegetable consumption among economically disadvantaged African-American adolescents: preliminary findings. Am J Health Promot 20 (2006) 342-348
37. McKinney E.F., Walton R.T., Yudkin P., Fuller A., Haldar N.A., Mant D., et al. Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics 10 (2000) 483-491
38. Ito H., Hamajima N., Matsuo K., Okuma K., Sato S., Ueda R., et al. Monoamine oxidase polymorphisms and smoking behaviour in Japanese. Pharmacogenetics 13 (2003) 73-79
39. Takahashi K., Saso H., Saka H., Saso H., Iwata M., Hashimoto I., et al. A pilot study on inducement of smoking cessation by a simple 5A (asking, advice, assess, assist, and arrange) approach at outpatient clinics. Asian Pac J Cancer Prev 7 (2006) 131-135